Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL260920 |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
protein tyrosine phosphatase non-receptor type 22/Hematopoietic cell protein-tyrosine phosphatase 70Z-PEP in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2889] [GtoPdb: 3084] [UniProtKB: Q9Y2R2] | ||||||||
ChEMBL | Inhibition of LYP expressed in Escherichia coli BL21 using increasing levels of ARLIED-NEpYTAREG substrate | B | 4.47 | pKi | 33870 | nM | Ki | J Med Chem (2011) 54: 1640-1654 [PMID:21341673] |
ChEMBL | Competitive inhibition of N-terminal 6xHis-tagged LYP catalytic domain (1 to 303) (unknown origin) expressed in Escherichia coli BL21(DE3) using pNPP as substrate by Dixon plot analysis | B | 5.54 | pKi | 2900 | nM | Ki | J Med Chem (2013) 56: 4990-5008 [PMID:23713581] |
GtoPdb | - | - | 5.54 | pKi | 2900 | nM | Ki | Proc Natl Acad Sci USA (2007) 104: 19767-72 [PMID:18056643] |
ChEMBL | Inhibition of lymphoid-specific tyrosine phosphatase F28A mutant | B | 4.46 | pIC50 | 35000 | nM | IC50 | Proc Natl Acad Sci U S A (2007) 104: 19767-19772 [PMID:18056643] |
ChEMBL | Inhibition of lymphoid-specific tyrosine phosphatase S35E mutant | B | 4.68 | pIC50 | 21000 | nM | IC50 | Proc Natl Acad Sci U S A (2007) 104: 19767-19772 [PMID:18056643] |
ChEMBL | Inhibition of lymphoid-specific tyrosine phosphatase K138A mutant | B | 4.72 | pIC50 | 19000 | nM | IC50 | Proc Natl Acad Sci U S A (2007) 104: 19767-19772 [PMID:18056643] |
ChEMBL | Inhibition of lymphoid-specific tyrosine phosphatase R33A mutant | B | 4.9 | pIC50 | 12500 | nM | IC50 | Proc Natl Acad Sci U S A (2007) 104: 19767-19772 [PMID:18056643] |
ChEMBL | Inhibition of lymphoid-specific tyrosine phosphatase L29A mutant | B | 4.93 | pIC50 | 11800 | nM | IC50 | Proc Natl Acad Sci U S A (2007) 104: 19767-19772 [PMID:18056643] |
ChEMBL | Inhibition of lymphoid-specific tyrosine phosphatase C129S mutant | B | 5.09 | pIC50 | 8100 | nM | IC50 | Proc Natl Acad Sci U S A (2007) 104: 19767-19772 [PMID:18056643] |
ChEMBL | Inhibition of lymphoid-specific tyrosine phosphatase | B | 5.34 | pIC50 | 4600 | nM | IC50 | Proc Natl Acad Sci U S A (2007) 104: 19767-19772 [PMID:18056643] |
ChEMBL | Inhibition of Lyp-mediated pNPP hydrolysis | B | 5.34 | pIC50 | 4600 | nM | IC50 | Bioorg Med Chem (2012) 20: 1940-1946 [PMID:22133902] |
ChEMBL | Inhibition of N-terminal 6xHis-tagged LYP catalytic domain (1 to 294) (unknown origin) expressed in Escherichia coli BL21(DE3) using pNPP as substrate by spectrometric analysis | B | 5.34 | pIC50 | 4600 | nM | IC50 | J Med Chem (2013) 56: 4990-5008 [PMID:23713581] |
GtoPdb | In vitro measurement of PTPN22-catalysed substrate dephosphorylation, using pNPP as a substrate at pH 7.0, 25°C, and ionic strength of 0.15 M. | - | 5.34 | pIC50 | 4600 | nM | IC50 | Proc Natl Acad Sci USA (2007) 104: 19767-72 [PMID:18056643] |
ChEMBL | Inhibition of recombinant LyP assessed as hydrolysis of DiFMUP | B | 5.35 | pIC50 | 4500 | nM | IC50 | J Med Chem (2011) 54: 562-571 [PMID:21190368] |
ChEMBL | Inhibition of lymphoid-specific tyrosine phosphatase T36E mutant | B | 5.55 | pIC50 | 2800 | nM | IC50 | Proc Natl Acad Sci U S A (2007) 104: 19767-19772 [PMID:18056643] |
protein tyrosine phosphatase non-receptor type 1/Protein-tyrosine phosphatase 1B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL335] [GtoPdb: 2976] [UniProtKB: P18031] | ||||||||
ChEMBL | Inhibition of PTP1B | B | 4.93 | pIC50 | 11800 | nM | IC50 | Proc Natl Acad Sci U S A (2007) 104: 19767-19772 [PMID:18056643] |
GtoPdb | - | - | 4.93 | pIC50 | 11800 | nM | IC50 | Proc Natl Acad Sci USA (2007) 104: 19767-72 [PMID:18056643] |
Protein-tyrosine phosphatase 1E in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2976] [UniProtKB: Q12923] | ||||||||
ChEMBL | Inhibition of FAP1 | B | 4.43 | pIC50 | 36800 | nM | IC50 | Proc Natl Acad Sci U S A (2007) 104: 19767-19772 [PMID:18056643] |
protein tyrosine phosphatase non-receptor type 11/Protein-tyrosine phosphatase 2C in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3864] [GtoPdb: 3203] [UniProtKB: Q06124] | ||||||||
ChEMBL | Inhibition of SHP2 | B | 4.44 | pIC50 | 36000 | nM | IC50 | Proc Natl Acad Sci U S A (2007) 104: 19767-19772 [PMID:18056643] |
Protein-tyrosine phosphatase LC-PTP in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2219] [UniProtKB: P35236] | ||||||||
ChEMBL | Inhibition of HePTP | B | 4.49 | pIC50 | 32100 | nM | IC50 | Proc Natl Acad Sci U S A (2007) 104: 19767-19772 [PMID:18056643] |
Tyrosine-protein phosphatase non-receptor type 9 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6117] [UniProtKB: P43378] | ||||||||
ChEMBL | Inhibition of PTP-Meg2 | B | 4.5 | pIC50 | 31800 | nM | IC50 | Proc Natl Acad Sci U S A (2007) 104: 19767-19772 [PMID:18056643] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]